Follow
Saranya Sridhar
Saranya Sridhar
Associate Vice President, Head of Translational Medicine,Global Clinical Development, Sanofi Pasteur
No verified email
Title
Cited by
Cited by
Year
Cellular immune correlates of protection against symptomatic pandemic influenza
S Sridhar, S Begom, A Bermingham, K Hoschler, W Adamson, W Carman, ...
Nature medicine 19 (10), 1305-1312, 2013
9152013
Effect of BCG vaccination against Mycobacterium tuberculosis infection in children: systematic review and meta-analysis
A Roy, M Eisenhut, RJ Harris, LC Rodrigues, S Sridhar, S Habermann, ...
British Medical Journal Publishing Group 349, g4643, 2014
6982014
Effect of dengue serostatus on dengue vaccine safety and efficacy
S Sridhar, A Luedtke, E Langevin, M Zhu, M Bonaparte, T Machabert, ...
New England Journal of Medicine 379 (4), 327-340, 2018
6942018
Influenza Vaccination Strategies: Comparing Inactivated and Live Attenuated Influenza Vaccines
S Sridhar, KA Brokstad, RJ Cox
Vaccines 3 (2), 373-389, 2015
2212015
Prognostic value of interferon-γ release assays and tuberculin skin test in predicting the development of active tuberculosis (UK PREDICT TB): a prospective cohort study
I Abubakar, F Drobniewski, J Southern, AJ Sitch, C Jackson, M Lipman, ...
The Lancet Infectious Diseases 18 (10), 1077-1087, 2018
1962018
Heterologous two-dose vaccination with simian adenovirus and poxvirus vectors elicits long-lasting cellular immunity to influenza virus A in healthy adults
L Coughlan, S Sridhar, R Payne, M Edmans, A Milicic, N Venkatraman, ...
EBioMedicine 29, 146-154, 2018
1492018
Heterologous two-dose vaccination with simian adenovirus and poxvirus vectors elicits long-lasting cellular immunity to influenza virus a in healthy adults
L Coughlan, S Sridhar, R Payne, M Edmans, A Milicic, N Venkatraman, ...
EBioMedicine 29, 146-154, 2018
1492018
Single‐dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei
A Reyes‐Sandoval, S Sridhar, T Berthoud, AC Moore, JT Harty, ...
European journal of immunology 38 (3), 732-741, 2008
1362008
Heterosubtypic T-cell immunity to influenza in humans: challenges for universal T-cell influenza vaccines
S Sridhar
Frontiers in immunology 7, 195, 2016
1102016
Enumeration of functional T-cell subsets by fluorescence-immunospot defines signatures of pathogen burden in tuberculosis
R Casey, D Blumenkrantz, K Millington, D Montamat-Sicotte, OM Kon, ...
PLoS One 5 (12), e15619, 2010
1052010
Clinical development of Ebola vaccines
S Sridhar
Therapeutic advances in vaccines 3 (5-6), 125-138, 2015
962015
Single-dose protection against Plasmodium berghei by a simian adenovirus vector using a human cytomegalovirus promoter containing intron A
S Sridhar, A Reyes-Sandoval, SJ Draper, AC Moore, SC Gilbert, GP Gao, ...
Journal of virology 82 (8), 3822-3833, 2008
782008
Harnessing local and systemic immunity for vaccines against tuberculosis
PCL Beverley, S Sridhar, A Lalvani, EZ Tchilian
Mucosal immunology 7 (1), 20-26, 2014
762014
Ethnicity and mycobacterial lineage as determinants of tuberculosis disease phenotype
M Pareek, J Evans, J Innes, G Smith, S Hingley-Wilson, KE Lougheed, ...
Thorax 68 (3), 221-229, 2013
762013
Prime and target immunization protects against liver-stage malaria in mice
A Gola, D Silman, AA Walters, S Sridhar, S Uderhardt, AM Salman, ...
Science translational medicine 10 (460), eaap9128, 2018
752018
Safety and Immunogenicity of a Heterologous Prime-Boost Ebola Virus Vaccine Regimen in Healthy Adults in the United Kingdom and Senegal
N Venkatraman, BP Ndiaye, G Bowyer, D Wade, S Sridhar, D Wright, ...
The Journal of infectious diseases 219 (8), 1187-1197, 2019
682019
A comparison between two strategies for monitoring hepatic function during antituberculous therapy
A Singanayagam, S Sridhar, J Dhariwal, D Abdel-Aziz, K Munro, ...
American journal of respiratory and critical care medicine 185 (6), 653-659, 2012
622012
Safety and immunogenicity of an AS03-adjuvanted SARS-CoV-2 recombinant protein vaccine (CoV2 preS dTM) in healthy adults: interim findings from a phase 2, randomised, dose …
S Sridhar, A Joaquin, MI Bonaparte, A Bueso, AL Chabanon, A Chen, ...
The Lancet Infectious Diseases 22 (5), 636-648, 2022
552022
Safety and efficacy of novel malaria vaccine regimens of RTS, S/AS01B alone, or with concomitant ChAd63-MVA-vectored vaccines expressing ME-TRAP
T Rampling, KJ Ewer, G Bowyer, NJ Edwards, D Wright, S Sridhar, ...
NPJ vaccines 3 (1), 49, 2018
552018
Predominance of heterosubtypic IFN-gamma-only-secreting effector memory T cells in pandemic H1N1 naive adults
S Sridhar, S Begom, A Bermingham, K Roberts, W Barclay, P Openshaw, ...
IMMUNOLOGY 135, 65-65, 2011
532011
The system can't perform the operation now. Try again later.
Articles 1–20